UB scientists Ranjit Singh and Bonnie Vest discuss dissemination and implementation science and upcoming CTSI workshops on the topic.

The company will present new clinical and early-stage pipeline data on long-acting and ultra long-acting HIV treatment and prevention, including the first-in-human results for VH184 and early findings ...

Individual-level attribution modeling reveals that real-world semaglutide effectiveness is not a fixed property of the molecule, but an interaction between pharmacological exposure and modifiable care ...

Data from the CLARITY study will provide insights on acceptability and tolerability of single-dose cabotegravir and lenacapavir long-acting injections Four-year analysis from the OPERA cohort examines ...

Real-world data (RWD) is transforming clinical research, augmenting existing randomized controlled trial (RCT) data to de-risk studies and improve generalizability. With regulators setting clearer ...

This study offers new insights to self-insured employers and health plans related to investment in digitally based disease management programs and enrollee engagement. Objective: To evaluate the ...

The life sciences industry is at a turning point. The pressures are mounting—shorten development timelines, meet regulatory demands and deliver therapies that patients actually need in the real world.

This story has been updated with additional comments from Datavant. Health tech company Datavant is making moves to be a bigger player in the real-world data space. The company announced Thursday that ...

Clayton Irvine, PharmD, MBA, MS, explains that leveraging high-quality, real-world data; cross-institutional collaboration; standardized care pathways; advanced technologies; and integrated ...